HARP
Harpoon Therapeutics, Inc. Common Stock
HARP
HARP
Delisted
HARP was delisted on the 8th of March, 2024.
52 hedge funds and large institutions have $18.1M invested in Harpoon Therapeutics, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 10 increasing their positions, 18 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
52% less capital invested
Capital invested by funds: $37.6M → $18.1M (-$19.5M)
79% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 14
Holders
52
Holding in Top 10
2
Calls
$18K
Puts
$10K
Top Buyers
| 1 | +$563K | |
| 2 | +$173K | |
| 3 | +$159K | |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$106K |
| 5 |
Millennium Management
New York
|
+$98.3K |
Top Sellers
| 1 | -$1.66M | |
| 2 | -$630K | |
| 3 | -$458K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$247K |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$137K |